Pfizer Inc’s new CEO on Tuesday outlined plans to reduce the company’s spending and work force and focus more sharply on promising drugs as it faces slowing sales of some of its blockbuster medicines.
In the latest quarter, a tax benefit and rising sales from products gained in its Wyeth acquisition helped Pfizer just beat Wall Street expectations. Profits nearly quadrupled, compared with a 2009 quarter hurt by big restructuring charges, but overall sales are slowing and the company said its revenue will drop next year.
Still, shares rose more than 5 percent on Tuesday as chief executive Ian Read announced a US$5 billion stock buyback and an ambitious overhaul of operations that will cut jobs and research spending while aiming to boost research productivity and emerging market sales. Pfizer will cut its 110,600-person work force by up to 5 percent.
The strategy outlined by Read includes many elements being tested across the pharmaceutical industry and tried by his predecessor, Jeffrey Kindler. He was ousted by Pfizer’s board unexpectedly on Dec. 6 after four years of languishing share prices and several failures of promising drugs in late testing, including a successor to cholesterol fighter Lipitor, the world’s top-selling drug.
“A lot of what we are doing individually you can see in different companies,” Read said, citing plans to increase external collaborations and prune the research portfolio to diseases with the best medical and financial payoffs. “I think we have a holistic game plan that is functioning as a total engine” to drive productivity.
The world’s largest drugmaker by revenue, Pfizer said fourth-quarter net income was US$2.89 billion, or US$0.36 per share, up from US$767 million, or US$0.10 a share, a year ago.
Adjusted net income was down 1 percent, at US$3.77 billion, or US$0.47 per share. Numerous one-time items brought a total gain of US$0.11 per share, including a US$2 billion benefit from a tax settlement, legal costs, and a host of restructuring and other expenses from Pfizer’s US$68 billion purchase of Wyeth in October 2009.
Revenue totaled US$17.56 billion, up 6 percent, as a dip in US sales was more than offset by higher sales elsewhere. For all of last year, Pfizer reported a 4 percent decline in net income, to US$8.26 billion, or US$1.02 per share. Revenue totaled US$67.81 billion, up 36 percent, thanks to US$18.1 billion from sales of Wyeth products.
Pfizer gave its first financial forecast for this year, for earnings per share of US$2.16 to US$2.26, excluding just over US$1 in one-time items. It expects flat revenue, at about US$67 billion.
Pfizer plans to cut research spending next year by US$1.5 billion, to about US$8.25 billion. The research cuts will come mainly from phasing out work in four disease areas: allergy and respiratory, urology, general medicine and tissue repair.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”